Astrazeneca (AZN) Net Income towards Common Stockholders (2009 - 2026)
Astrazeneca (AZN) reported Net Income towards Common Stockholders of $3.12 billion for Q3 2026, up 23.1% from $2.53 billion a year earlier and up 24.3% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Astrazeneca's Net Income towards Common Stockholders came in at $11.03 billion, up 17.4% year-over-year; for FY2025, it was $10.23 billion, up 45.3% from FY2024.
- Net Income towards Common Stockholders has increased for three consecutive years, with a five-year compound annual growth rate of 26.2% (FY2020 to FY2025).
- By year, Net Income towards Common Stockholders came in at $7.04 billion in FY2024 (+18.1%), $5.96 billion in FY2023 (+81.1%), $3.29 billion in FY2022 and $112 million in FY2021 (-96.5%).
- The Q3 2026 figure ranks as the highest quarterly Net Income towards Common Stockholders since Q4 2014.
- Year over year, Net Income towards Common Stockholders has now increased in each of the last 12 quarters, with growth averaging 35.1% over the last eight quarters.
- The high point for year-over-year Net Income towards Common Stockholders in five years was Q2 2023 (growth of 405.6%); the low point was Q1 2022 (a decline of 75.3%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $2.51 billion (Q2 2026), $3.08 billion (Q1 2026) and $2.33 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 3.24 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 653.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.12 Bn |
| Jun 30, 2026 | 2.51 Bn |
| Mar 31, 2026 | 3.08 Bn |
| Dec 31, 2025 | 2.33 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.45 Bn |
| Mar 31, 2025 | 2.92 Bn |
| Dec 31, 2024 | 1.50 Bn |
| Sep 30, 2024 | 1.43 Bn |
| Jun 30, 2024 | 1.93 Bn |
| Mar 31, 2024 | 2.18 Bn |
| Dec 31, 2023 | 960.00 Mn |
| Sep 30, 2023 | 1.37 Bn |
| Jun 30, 2023 | 1.82 Bn |
| Mar 31, 2023 | 1.80 Bn |
| Dec 31, 2022 | 901.00 Mn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 360.00 Mn |
| Mar 31, 2022 | 386.00 Mn |
| Dec 31, 2021 | -347.00 Mn |
API Access
Astrazeneca Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();